Form 4: Korro Bio Director & 10% Owner Boosts Stake

Korro Bio Director and 10% owner Ali Behbahani, through New Enterprise Associates 17, L.P., acquired 207,100 shares of common stock and 242,945 pre-funded warrants from the issuer on March 10, 2026.

Summary

• Ali Behbahani, a Director and 10% Owner of Korro Bio, Inc. (KRRO), indirectly acquired additional securities through New Enterprise Associates 17, L.P. (NEA 17).
• The acquisition occurred on March 10, 2026, directly from the Issuer pursuant to a Subscription Agreement dated March 9, 2026.
• Securities acquired include 207,100 shares of Common Stock at a price of $11.11 per share.
• Additionally, 242,945 Pre-Funded Warrants were acquired, with an exercise price of $0.001 and an effective acquisition price of $11.109 per underlying share.
• Following these transactions, the indirect beneficial ownership by NEA 17 stands at 1,297,893 shares of Common Stock and 242,945 Pre-Funded Warrants.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.
• The Pre-Funded Warrants are exercisable at any time, subject to a limitation that prevents the holder from exceeding 9.99% of the Issuer's Common Stock immediately after exercise, which can be increased to 19.99% with 61 days' prior notice.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal, as a director and 10% owner significantly increased their stake, indicating high confidence in Korro Bio's future.

Positives

• A Director and 10% owner, Ali Behbahani, significantly increased their stake in Korro Bio, signaling strong confidence in the company's future prospects and valuation.
• The acquisition was made through a Rule 10b5-1 plan, which suggests a pre-planned investment strategy rather than a reactive market decision.

Negatives

• No explicit negatives are detailed in this Form 4 filing, which primarily reports a transaction rather than operational or financial performance.

Risks

• The Pre-Funded Warrants have an exercise limitation, preventing the holder from exceeding 9.99% ownership immediately after exercise, which could limit immediate full conversion. This cap can be increased to 19.99% with 61 days' prior notice to the Issuer.

Future Outlook

This Form 4 filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider buying, particularly by a director and significant shareholder like Ali Behbahani, is often interpreted by the market as a strong signal of confidence in the company's valuation and future prospects. Such transactions can sometimes precede positive company developments or reflect a belief that the stock is undervalued relative to its intrinsic worth.

Related Party Transactions

• Ali Behbahani, a Director and 10% Owner of Korro Bio, Inc., indirectly acquired securities from the Issuer.
• The transaction was conducted through New Enterprise Associates 17, L.P., where Mr. Behbahani is a manager of the general partner.

Stakeholder Impact

• Shareholders may view the significant insider purchase as a vote of confidence from a key director and major investor, potentially leading to increased investor interest and positive sentiment.
• Company Management's interests are further aligned with the company's long-term success due to the increased investment from a director and 10% owner.

Next Steps

• This filing does not explicitly mention future actions, events, or milestones for Korro Bio, Inc.

Key Dates

Recommendation

The significant acquisition of common stock and warrants by a director and 10% owner, Ali Behbahani, through NEA 17, signals strong insider confidence in Korro Bio's future prospects and valuation. Such a substantial investment by a well-informed party often suggests an expectation of future positive performance, making it a compelling 'buy' signal for investors.

Keywords

Korro Bio, KRRO, Insider Buying, Form 4, Ali Behbahani, New Enterprise Associates, NEA 17, Common Stock, Pre-Funded Warrants, Beneficial Ownership, Director, 10% Owner, Rule 10b5-1